Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if it is effective to add an HIV vaccine (Remune) to the
anti-HIV drug combination of Combivir (zidovudine plus lamivudine) and nelfinavir.
Phase:
Phase 3
Details
Lead Sponsor:
Agouron Pharmaceuticals
Treatments:
Lamivudine Lamivudine, zidovudine drug combination Nelfinavir Zidovudine